2.600
−7,14%
2026-10-16
Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +21.8% | -18.9% | 1 / 3 | +68.2% | -3.17 pp | -1.26 pp | -12.1% | 0.00 | 36.16 | 25,1 | +68,2% | 0,8 | +21,8% | 36.16 | 16.93 | +113,6% |
| Pts | 4 | 0 | 4 | 12 | 0 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 2.600 (close price on 2026-10-16)EPS (TTM): 71,9
Financial charts
1.Revenue & growth
VND bn25,1Q2/26
1.Revenue & growth
VND bn25,1Q2/26
2.Profit & growth
VND bn0,83Q2/26
3.Profit mix (Penman)
VND bn3,37Q2/26
4.Margins & cost structure
%6.3%Q2/26
5.Returns & cash cycle
% · days-12.0%Q2/26
6.Earnings quality & cash
VND bn6,71Q2/26
7.Asset structure
VND bn64,2Q2/26
8.Funding & debt health
VND bn · times64,2Q2/26
9.Revenue backlog
VND bn44,1Q2/26
10.Valuation
times · %36,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %23Q2/26
Adjusted EPS growth, latest quarter
21.8%
Average adjusted EPS growth, 3 quarters
-18.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26